Is targeted lung cancer screening an opportune time to address cardiovascular risk? | Thorax

Subscribe
Log In More

Log in via Institution
Log in via OpenAthens

Log in using your username and password
For personal accounts OR managers of institutional accounts

Username *

Password *

Forgot your log in details?Register a new account?
Forgot your user name or password?
Basket
Search More

Search for this keyword

Advanced search

Article info

Editorial

Is targeted lung cancer screening an opportune time to address cardiovascular risk?

Free

Authors

Marie Fisk Respiratory Medicine & Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke’s Hospital, Cambridge, UK PubMed articles Google scholar articles
Charlotte E Bolton Respiratory Medicine, NIHR Nottingham Biomedical Research Centre Respiratory Theme, University of Nottingham, Nottingham, UK PubMed articles Google scholar articles

Correspondence to Dr Marie Fisk, Respiratory Medicine & Division of Experimental Medicine and Immunotherapeutics, University of Cambridge, Addenbrooke’s Hospital, Cambridge CB2 0QQ, UK; mf503{at}medschl.cam.ac.uk

Citation

Fisk M, Bolton CE

Is targeted lung cancer screening an opportune time to address cardiovascular risk?

Thorax 2019;74:1107-1108.

Publication history

Accepted August 7, 2019
First published September 26, 2019.

Online issue publication

September 01, 2022

Article Versions

Previous version (14 November 2019).
You are viewing the most recent version of this article.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2019. No commercial re-use. See rights and permissions. Published by BMJ.